Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalyst Bio (NQ: CBIO )

4.740 USD -0.140 (-2.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 160,483
Open 4.880
Bid (Size) 4.610 (1)
Ask (Size) 4.750 (2)
Prev. Close 4.880
Today's Range 4.730 - 4.950
52wk Range 3.720 - 7.550
Shares Outstanding 31,365,701
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
From GlobeNewswire News Releases
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
Management to discuss CBIO’s complement portfolio including the potential of CB 2782-PEG in dry AMD 
From GlobeNewswire News Releases

Performance

YTD
-23.05%
-23.05%
1 Month
+8.97%
+8.97%
3 Month
+3.04%
+3.04%
6 Month
-4.05%
-4.05%
1 Year
+6.28%
+6.28%

More News

Read More
Catalyst Biosciences Announces Oral and Poster Presentations at the International Conference on Complement Therapeutics
From GlobeNewswire News Releases
Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors
From GlobeNewswire News Releases
Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies
From GlobeNewswire News Releases
Catalyst Biosciences Presents Four Posters at the International Society for Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress
From GlobeNewswire News Releases
Catalyst Biosciences Announces Key Leadership Changes in its Ongoing Transition to an Integrated Protease Medicines Company
From GlobeNewswire News Releases
Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis
From GlobeNewswire News Releases
Catalyst Biosciences to Host Research and Development Day on CB 4332 and Complement Programs
From GlobeNewswire News Releases
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Factor VII Deficiency
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.